Literature DB >> 15477046

Migration and maturation of human dendritic cells infected with Toxoplasma gondii depend on parasite strain type.

Julien Diana1, Florence Persat, Marie-Jeanne Staquet, Olga Assossou, Josette Ferrandiz, Marie-Jo Gariazzo, François Peyron, Stéphane Picot, Daniel Schmitt, Claude Vincent.   

Abstract

Migration and maturation of human dendritic cells derived from CD34+ progenitor cells (DC) infected by Toxoplasma gondii were studied in an in vitro model. We demonstrated that infection with virulent type I strains RH and ENT or type II low virulent strains PRU and CAL induced DC migration towards MIP-3beta. However, type II strains induced a higher percentage of migrating cells than that induced by type I strains or positive controls (chemical allergen or lipopolysaccharides). Type II strains produced soluble factors responsible of the high migration whereas heat killed tachyzoites did not induced a migration higher than positive controls. We also demonstrated that infection by virulent strains and not by type II stains or heat killed tachyzoites triggers DC maturation. A soluble factor released by type II strains was responsible of the absence of DC maturation. Taken together, these results demonstrated that the interference of T. gondii in the behaviour of DC functions is related to the strain types and can be supported by secretion of soluble factors by the parasite.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15477046     DOI: 10.1016/j.femsim.2004.06.021

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  9 in total

1.  Toxoplasma gondii regulates recruitment and migration of human dendritic cells via different soluble secreted factors.

Authors:  J Diana; C Vincent; F Peyron; S Picot; D Schmitt; F Persat
Journal:  Clin Exp Immunol       Date:  2005-09       Impact factor: 4.330

Review 2.  Modulation of dendritic cell responses by parasites: a common strategy to survive.

Authors:  César A Terrazas; Luis I Terrazas; Lorena Gómez-García
Journal:  J Biomed Biotechnol       Date:  2010-02-24

3.  Virulence of Toxoplasma gondii is associated with distinct dendritic cell responses and reduced numbers of activated CD8+ T cells.

Authors:  Elia D Tait; Kimberly A Jordan; Christopher D Dupont; Tajie H Harris; Beth Gregg; Emma H Wilson; Marion Pepper; Florence Dzierszinski; David S Roos; Christopher A Hunter
Journal:  J Immunol       Date:  2010-06-30       Impact factor: 5.422

4.  Toxoplasma gondii-derived heat shock protein 70 stimulates maturation of murine bone marrow-derived dendritic cells via Toll-like receptor 4.

Authors:  Fumie Aosai; Martha S Rodriguez Pena; Hye-Seong Mun; Hao Fang; Tetsuya Mitsunaga; Kazumi Norose; Hyun Kyu Kang; Yoe-Sik Bae; Akihiko Yano
Journal:  Cell Stress Chaperones       Date:  2006       Impact factor: 3.667

Review 5.  Unifying Virulence Evaluation in Toxoplasma gondii: A Timely Task.

Authors:  Rafael Calero-Bernal; Mercedes Fernández-Escobar; Frank Katzer; Chunlei Su; Luis Miguel Ortega-Mora
Journal:  Front Cell Infect Microbiol       Date:  2022-04-28       Impact factor: 6.073

6.  Toxoplasma gondii infection, from predation to schizophrenia: can animal behaviour help us understand human behaviour?

Authors:  Joanne P Webster; Maya Kaushik; Greg C Bristow; Glenn A McConkey
Journal:  J Exp Biol       Date:  2013-01-01       Impact factor: 3.312

Review 7.  Communication between Toxoplasma gondii and its host: impact on parasite growth, development, immune evasion, and virulence.

Authors:  Ira J Blader; Jeroen P Saeij
Journal:  APMIS       Date:  2009-05       Impact factor: 3.205

Review 8.  Calling in the CaValry-Toxoplasma gondii Hijacks GABAergic Signaling and Voltage-Dependent Calcium Channel Signaling for Trojan horse-Mediated Dissemination.

Authors:  Amol K Bhandage; Antonio Barragan
Journal:  Front Cell Infect Microbiol       Date:  2019-03-20       Impact factor: 5.293

Review 9.  Use and abuse of dendritic cells by Toxoplasma gondii.

Authors:  Anna Sanecka; Eva-Maria Frickel
Journal:  Virulence       Date:  2012-11-15       Impact factor: 5.882

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.